We predict that this collaborative effort can result in research breakthroughs, which will not only bring new hope but also create a new class of anticancer drugs that will help millions of cancer patients and those at high risk for this disease in both our countries and will benefit the world population at large.
However, when reservoir layers have significantly different petro-physical properties, WAG can result in early breakthrough of the injected water and/or injected gas in layers with unfavorable physical characteristics.
Formation of gas flow pathways, either caused by capillary pressure or mechanical stress, can result in gas breakthrough, the corresponding pressure of which is determined according to the evolution of gas flow rate and can be used as the working gas pressure for avoiding significant gas loss in the gas-tight working structures in pneumatic caisson method and compressed air tunneling technique.
Monthly and daily formulations increase the likelihood that patients may delay or miss treatments, which can result in testosterone breakthrough and potentially compromise tumor control and increase symptom progression.
For example, higher than recommended air flow rates, used in order to achieve lower than standard levels of detection, can result in sample breakthrough, MMA loss, and underestimation of exposure.
Treatment with the shorter-acting variations such as 1-month depot and daily formulations presents more opportunities for patients to delay or altogether miss treatments, which can result in testosterone breakthrough and potentially deleterious effects on tumor control and symptom progression.
Both the experimental and theoretical results have shown that 2D semiconductors have exceptional properties that can result in novel and important breakthroughs in the field of nanomaterials and nanodevices.
Generally, the existent of heterogeneity in porous medium can result in gas flowing to bigger pore throat which has bad effect on its sweeping efficiency and would cause earlier gas breakthrough.
Hence, monotherapy with NS3-4A inhibitors can result in an approximately 4 log10 decrease of serum HCV RNA within days, but also in rapid selection of resistant variants and viral breakthrough (Lange & Zeuzem, 2012).
That can take some time and breakthroughs can come unexpectedly.
